Cargando…

Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma

BACKGROUND: Systemic corticosteroids are a leading cause of drug-related complications, yet little has been done to quantify the dose-response relationship between systemic corticosteroid exposure and complications in patients with severe asthma. OBJECTIVES: To (a) evaluate the risk of developing sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Anand A., Duh, Mei Sheng, Gozalo, Laurence, Robitaille, Marie-Noëlle, Albers, Frank, Yancey, Steve, Ortega, Hector, Forshag, Mark, Lin, Xiwu, Lefebvre, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397753/
https://www.ncbi.nlm.nih.gov/pubmed/27348284
http://dx.doi.org/10.18553/jmcp.2016.22.7.833
_version_ 1785083963355693056
author Dalal, Anand A.
Duh, Mei Sheng
Gozalo, Laurence
Robitaille, Marie-Noëlle
Albers, Frank
Yancey, Steve
Ortega, Hector
Forshag, Mark
Lin, Xiwu
Lefebvre, Patrick
author_facet Dalal, Anand A.
Duh, Mei Sheng
Gozalo, Laurence
Robitaille, Marie-Noëlle
Albers, Frank
Yancey, Steve
Ortega, Hector
Forshag, Mark
Lin, Xiwu
Lefebvre, Patrick
author_sort Dalal, Anand A.
collection PubMed
description BACKGROUND: Systemic corticosteroids are a leading cause of drug-related complications, yet little has been done to quantify the dose-response relationship between systemic corticosteroid exposure and complications in patients with severe asthma. OBJECTIVES: To (a) evaluate the risk of developing systemic corticosteroid-related complications by corticosteroid exposure in severe asthma and (b) quantify the associated health care resource utilization and costs. METHODS: This is a retrospective study using administrative claims data from a large commercial database between 2003 and 2014. Multivariate generalized estimating equation models were used to compare corticosteroid-related complications in patients continuously exposed to at least 5 mg of prednisone or equivalent for ≥ 6 months with a 1:1 ratio of propensity score-matched patients with asthma who did not use corticosteroids. RESULTS: A total of 12,697 corticosteroid users and as many matched nonusers were identified. The odds of developing associated complications increased significantly in a dose-dependent manner with systemic corticosteroid exposure: odds ratios were 2.50, 2.95, and 3.32 (P values <0.05) for low (defined as < 5 mg/day), medium (≥ 5-10 mg/day), and high (>10 mg/day) exposure, respectively, relative to no exposure. Health care resource utilization increased significantly with levels of systemic corticosteroid exposure. Hence, incidence rate ratios for inpatient visits with low, medium, and high exposure relative to none were estimated to be 1.86, 2.40, and 3.37, respectively (P < 0.05). CONCLUSIONS: A significant dose-response relationship was found between the long-term use of systemic corticosteroids and the risk of developing systemic corticosteroid-related complications in patients with severe asthma, resulting in increased burden and costs on the health care system that intensified with systemic corticosteroid exposure.
format Online
Article
Text
id pubmed-10397753
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103977532023-08-04 Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma Dalal, Anand A. Duh, Mei Sheng Gozalo, Laurence Robitaille, Marie-Noëlle Albers, Frank Yancey, Steve Ortega, Hector Forshag, Mark Lin, Xiwu Lefebvre, Patrick J Manag Care Spec Pharm Research BACKGROUND: Systemic corticosteroids are a leading cause of drug-related complications, yet little has been done to quantify the dose-response relationship between systemic corticosteroid exposure and complications in patients with severe asthma. OBJECTIVES: To (a) evaluate the risk of developing systemic corticosteroid-related complications by corticosteroid exposure in severe asthma and (b) quantify the associated health care resource utilization and costs. METHODS: This is a retrospective study using administrative claims data from a large commercial database between 2003 and 2014. Multivariate generalized estimating equation models were used to compare corticosteroid-related complications in patients continuously exposed to at least 5 mg of prednisone or equivalent for ≥ 6 months with a 1:1 ratio of propensity score-matched patients with asthma who did not use corticosteroids. RESULTS: A total of 12,697 corticosteroid users and as many matched nonusers were identified. The odds of developing associated complications increased significantly in a dose-dependent manner with systemic corticosteroid exposure: odds ratios were 2.50, 2.95, and 3.32 (P values <0.05) for low (defined as < 5 mg/day), medium (≥ 5-10 mg/day), and high (>10 mg/day) exposure, respectively, relative to no exposure. Health care resource utilization increased significantly with levels of systemic corticosteroid exposure. Hence, incidence rate ratios for inpatient visits with low, medium, and high exposure relative to none were estimated to be 1.86, 2.40, and 3.37, respectively (P < 0.05). CONCLUSIONS: A significant dose-response relationship was found between the long-term use of systemic corticosteroids and the risk of developing systemic corticosteroid-related complications in patients with severe asthma, resulting in increased burden and costs on the health care system that intensified with systemic corticosteroid exposure. Academy of Managed Care Pharmacy 2016-07 /pmc/articles/PMC10397753/ /pubmed/27348284 http://dx.doi.org/10.18553/jmcp.2016.22.7.833 Text en © 2016, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
Dalal, Anand A.
Duh, Mei Sheng
Gozalo, Laurence
Robitaille, Marie-Noëlle
Albers, Frank
Yancey, Steve
Ortega, Hector
Forshag, Mark
Lin, Xiwu
Lefebvre, Patrick
Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title_full Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title_fullStr Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title_full_unstemmed Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title_short Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
title_sort dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397753/
https://www.ncbi.nlm.nih.gov/pubmed/27348284
http://dx.doi.org/10.18553/jmcp.2016.22.7.833
work_keys_str_mv AT dalalananda doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT duhmeisheng doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT gozalolaurence doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT robitaillemarienoelle doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT albersfrank doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT yanceysteve doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT ortegahector doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT forshagmark doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT linxiwu doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma
AT lefebvrepatrick doseresponserelationshipbetweenlongtermsystemiccorticosteroiduseandrelatedcomplicationsinpatientswithsevereasthma